Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Death by One-Third Versus Chemotherapy With or Without Bevacizumab as First-Line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of the full results…
Merck’s KEYTRUDA® (pembrolizumab) Demonstrated Superior Recurrence-Free Survival (RFS) in Patients With Resected High-Risk Stage II Melanoma Compared to Placebo in the Adjuvant Setting
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the first results from the Phase…
Spectrum Pharmaceuticals Presents Late Breaker Oral Presentation of Poziotinib Data in First-Line NSCLC Patients with HER2 Exon 20 Insertion Mutations at ESMO Congress 2021
Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the presentation of…
Exelixis Announces Detailed Phase 1b Results from Cohort 6 of COSMIC-021 Trial in Patients with Metastatic Castration-Resistant Prostate Cancer Presented at ESMO 2021
Exelixis, Inc. (Nasdaq: EXEL) today announced detailed results from the expanded cohort 6 of the phase 1b COSMIC-021 trial of…
Lufax Joins FTSE ESG Low Carbon Select Indexes
Lufax Holding Ltd (“Lufax” or the “Company”) (NYSE: LU), a leading technology-empowered personal financial services platform in China, today announced…
TTEC Resolves Cyber Incident
TTEC Holdings, Inc. (NASDAQ: TTEC), one of the largest global CX (customer experience) technology and services innovators for end-to-end digital…
FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-risk Populations
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines…
Astellas’ and Pfizer’s XTANDI® (enzalutamide) Reduced Risk of Death by 34% in Men with Metastatic Hormone-Sensitive Prostate Cancer in Phase 3 ARCHES Study
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Pfizer Inc. (NYSE: PFE) announced today ahead…
Douglas Emmett To Participate In BofA Securities 2021 Global Real Estate Conference
Douglas Emmett, Inc. (NYSE: DEI), a real estate investment trust (REIT), announced today that President and CEO Jordan L. Kaplan…
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein…
PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend
PerkinElmer, Inc. (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced it has completed its…
Olympic Steel Announces Sale of Detroit Assets and Operations
Olympic Steel, Inc. (Nasdaq: ZEUS), a leading national metals service center, today announced the sale of substantially all of the…
Peoples Bancorp Completes Acquisition Of Premier Financial Bancorp
Peoples Bancorp Inc. (“Peoples”) (Nasdaq: PEBO), parent company of Peoples Bank, announced today that it has completed its acquisition of…
Aptiv to Present at the Evercore ISI Autotech & AI Forum: New Paradigms In Mobility, Electrification, & Compute
Aptiv PLC (NYSE: APTV), a global technology company focused on making mobility safer, greener, and more connected, announced that Aptiv’s…
Guess?, Inc. Announces Participation at the Annual Wells Fargo Consumer Conference
Guess?, Inc. (NYSE: GES) announced today that the Company will be participating in a fireside chat at the Annual Wells…
KKR Expands Industrial Real Estate Footprint in Atlanta with Acquisition by KREST
KKR, a leading global investment firm, today announced that KKR Real Estate Select Trust Inc. (“KREST”) has acquired a 1.1…
Exelixis Announces U.S. FDA Approval of CABOMETYX® (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Exelixis, Inc. (Nasdaq: EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved CABOMETYX® (cabozantinib) for the treatment…
Shoe Carnival Declares Quarterly Cash Dividend
Shoe Carnival, Inc. (Nasdaq: SCVL) (the “Company”), a leading retailer of footwear and accessories for the family, announced today that…
JLL arranges $381M construction loan for Bronx Logistics Center
JLL announced today that its Capital Markets group arranged $381 million in construction financing for the development of Bronx Logistics…
Flora Growth Announces Unaudited Financial Results for the Six Month Period Ended June 30, 2021
Flora Growth Corp. (“Flora” or the “Company’) (NASDAQ: FLGC), an all-outdoor cultivator and manufacturer of cannabis-derived products and brands, today…